Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Debt Ratio (2022 - 2025)

Historic Debt Ratio for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to 0.0.

  • bioAffinity Technologies' Debt Ratio rose 1427.57% to 0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0, marking a year-over-year increase of 1427.57%. This contributed to the annual value of 0.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that bioAffinity Technologies reported Debt Ratio of 0.0 as of Q3 2025, which was up 1427.57% from 0.01 recorded in Q2 2025.
  • bioAffinity Technologies' Debt Ratio's 5-year high stood at 0.04 during Q3 2022, with a 5-year trough of 0.0 in Q1 2024.
  • Over the past 4 years, bioAffinity Technologies' median Debt Ratio value was 0.0 (recorded in 2023), while the average stood at 0.01.
  • In the last 5 years, bioAffinity Technologies' Debt Ratio crashed by 8221.84% in 2024 and then skyrocketed by 20331.96% in 2025.
  • Over the past 4 years, bioAffinity Technologies' Debt Ratio (Quarter) stood at 0.02 in 2022, then plummeted by 76.91% to 0.0 in 2023, then crashed by 35.06% to 0.0 in 2024, then grew by 22.05% to 0.0 in 2025.
  • Its Debt Ratio was 0.0 in Q3 2025, compared to 0.01 in Q2 2025 and 0.01 in Q1 2025.